SHC
NASDAQSotera Health Company
Price$15.34-0.04 (-0.26%)
01:30 PM07:45 PM
News · 26 weeks61-69%
2025-10-262026-04-19
Mix3290d
- Insider12(38%)
- Other8(25%)
- SEC Filings7(22%)
- Earnings3(9%)
- Leadership1(3%)
- Offering1(3%)
Latest news
25 items- PRSotera Health Announces First-Quarter 2026 Earnings Release DateCLEVELAND, April 21, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the first-quarter ended March 31, 2026 before the market opens on Tuesday, May 5, 2026. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company's operating and financial results. A live webcast of the conference call and accompanying materials can be accessed via the Investor Relations section of the Company's website at Presentation & Event
- SECSEC Form DEFA14A filed by Sotera Health CompanyDEFA14A - Sotera Health Co (0001822479) (Filer)
- SECSEC Form DEF 14A filed by Sotera Health CompanyDEF 14A - Sotera Health Co (0001822479) (Filer)
- INSIDERSEC Form 3 filed by new insider Ostrowski Erika3 - Sotera Health Co (0001822479) (Issuer)
- INSIDERSEC Form 4 filed by Dimitrief Alexander4 - Sotera Health Co (0001822479) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Sotera Health CompanySCHEDULE 13G/A - Sotera Health Co (0001822479) (Subject)
- INSIDERSEC Form 3 filed by new insider Krause Kenneth D.3 - Sotera Health Co (0001822479) (Issuer)
- SECSotera Health Company filed SEC Form 8-K: Leadership Update8-K - Sotera Health Co (0001822479) (Filer)
- PRSotera Health Appoints Kenneth D. Krause to the Board of DirectorsCLEVELAND, March 16, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC) (the "Company" or "Sotera Health"), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, announced today that it has appointed Kenneth D. Krause as a new independent director to its Board of Directors (the "Board"). Mr. Krause has served as Executive Vice President and Chief Financial Officer of Rollins, Inc. (NYSE:ROL) ("Rollins"), a global consumer and commercial pest control services company, since September 2022. In 2024, his role expanded to include oversight of Rollins' International Brands. During his tenure at
- INSIDERDirector Warburg Pincus & Co. sold $229,050,000 worth of shares (15,000,000 units at $15.27) (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Warburg Pincus & Co. sold $229,050,000 worth of shares (15,000,000 units at $15.27) (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Sotera Health CompanySCHEDULE 13G/A - Sotera Health Co (0001822479) (Subject)
- INSIDERDirector Gtcr Investment Xi Llc sold $152,700,000 worth of shares (10,000,000 units at $15.27) (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- SECSEC Form 8-K filed by Sotera Health Company8-K - Sotera Health Co (0001822479) (Filer)
- SECSEC Form 424B7 filed by Sotera Health Company424B7 - Sotera Health Co (0001822479) (Filer)
- INSIDERChairman & CEO Petras Michael B. Jr. covered exercise/tax liability with 190,297 shares, converted options into 89,686 shares and was granted 240,248 shares, increasing direct ownership by 25% to 692,427 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERSVP, General Counsel and Sec. Dimitrief Alexander covered exercise/tax liability with 31,560 shares and converted options into 16,816 shares, decreasing direct ownership by 4% to 319,981 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERSr. Vice President, CFO Lyons Jonathan M. covered exercise/tax liability with 38,274 shares, converted options into 17,937 shares and was granted 59,355 shares, increasing direct ownership by 21% to 228,620 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERPresident of Sterigenics Rutz Michael P was granted 45,223 shares, covered exercise/tax liability with 25,721 shares and converted options into 14,573 shares, increasing direct ownership by 8% to 484,279 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- SECSEC Form 424B7 filed by Sotera Health Company424B7 - Sotera Health Co (0001822479) (Filer)
- PRSotera Health Announces Secondary Offering of Common StockCLEVELAND, March 04, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC) (the "Company") today announced the launch of a secondary offering (the "Offering") of 25 million shares of its common stock, par value $0.01 per share. All 25 million shares are being offered for sale by certain affiliates of Warburg Pincus LLC ("Warburg Pincus") and GTCR LLC ("GTCR") as selling stockholders. No other entities, and no individuals, are selling shares in the Offering. The Company is not offering any shares in the Offering and will not receive any of the proceeds from the Offering. The Company will pay the expenses of the Offering pursuant to its obligations under its Amended and Restated Regist
- SECSEC Form 10-K filed by Sotera Health Company10-K - Sotera Health Co (0001822479) (Filer)
- SECSotera Health Company filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits8-K - Sotera Health Co (0001822479) (Filer)
- PRSotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook2025 net revenues increased 5.7% to $1.164 billion, compared to 2024, or 5.2% on a constant currency basis2025 net income increased to $78 million or $0.27 per diluted share, compared to net income of $44 million, or $0.16 per diluted share, in 20242025 Adjusted EBITDA(1) increased 8.2% to $594 million, compared to 2024, or 7.8% on a constant currency basis2025 Adjusted EPS(1) of $0.86, an increase of $0.16 per diluted share, compared to 2024Full-year 2026 outlook: net revenues growth of 5.0% to 6.5% and Adjusted EBITDA growth of 5.5% to 7.0%, on a constant currency basis CLEVELAND, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company ("Sotera Health" or the "Company") (NASDAQ:SHC),
- SECSEC Form SCHEDULE 13G filed by Sotera Health CompanySCHEDULE 13G - Sotera Health Co (0001822479) (Subject)